Suggest - Business

If you sought near term investment returns that were lucrative and dividend paying, would you select a poorly performing stock, like that of GM? On the other hand, if you c

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

ould experience a return on investment based on GM's sale of vehicles paying a little piece of revenue to you every time there was a car sold, an investment in GM may be quite prof

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

itable for you.

Our company provides this unique way of generating revenue for your launch phase. Through a creative funding program, your company finds dollars for your start up

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

by agreeing to share gross revenue with the founding sales force of your company. For every purchase of your primary product, whatever that may be, the founding sales force receiv

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

s a share of 5% set aside specifically for this purpose. Let me share a few significant advantages of this type of arrangement, some disadvantages, and then some qualities of compa

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

nies most likely to benefit from this type of significantly different method of funding.

Some of the advantages include the ability to receive funding from "angels" without giving

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

up stock or equity. Those people close to the founders who would have generally been interested in stock ownership discovered with this method that they could share in the gross r

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

evenue of the entire company without having to wait on profitability or annual accounting. A second advantage was the significantly reduced paperwork. Our company did not need to a

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

thor a complex private placement memorandum meeting the strict legal requirements such documents require. A third advantage surrounded the unique nature of the relationship between

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

the founding sales force and the company. By virtue of their understanding of your company's business model, they will now be actively engaged in promoting the company, it's busin

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

ess, and all of it's sales reps. Since they have a stake in every product sold, they are proactive in your corporate promotion.

Disadvantages are few but the first would be the do

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

uble edge side of sharing a unique program with a traditionally minded professional. When one has spent his/her life in traditional business models, sharing corporate gross revenue

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

on product sales is a very new concept. You have to be able to share the specific nature of your product, it's place in the market, why sales are likely to occur and why your compa

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

ny features the management team to pull it all off. Another consideration, do you want involvement? If you don't feel your company is a fit for a collaborative group of founding di

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

stributors, this model may not be a fit. When you are not sharing equity in your company but still accepting cash in return for gross sales participation, you need to be ready to c

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

ommunicate, communicate, and communicate some more. What companies may be a candidate for this type of funding? They feature adequate margins in their product lines to share the we

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

lth. They have management teams in place that have deep relationships with people who have the ability to purchase this type of future revenue stream, without equity ownership. The

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

executive team has to be equipped to communicate effectively with interested parties concerning this different method of funding. One could sum it up this way, you have to first

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

become a student of that you wish to teach. This tool for funding was developed after years of legal counsel and research. We employed the expertise of a attorney's, consultants, a

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

nd financial experts. Thus far 32 companies have experienced revenue generation totaling $70 million plus with this method. Great success to you as you begin your journey to launch

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.suggest.org.ua/article/18102/suggest-Funding-Your-StartUp-Without-Selling-Equity.html">Funding Your Start-Up Without Selling Equity</a>

BB link (for phorums):
[url=http://www.suggest.org.ua/article/18102/suggest-Funding-Your-StartUp-Without-Selling-Equity.html]Funding Your Start-Up Without Selling Equity[/url]

Designing your own marketing materials when you launch your business, instead of having them professionally created, will make getting initial clients more difficult, and may result in a business that will not succeed. Here are several reasons why this is not the best idea.

Pothole Pictures: Normally this name wouldn't create a positive image for a movie theater. But in Shelburne Falls, Massachusetts, where glacial potholes in the Deerfield River running through the vil...

Tags

Links

Suggest - Funding Your Start-Up Without Selling Equity

Related Articles: